Verrica Pharmaceuticals Inc.

US$3.19As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VRCAHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (38.95%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.67
PE TTM —
TSR TTM (11.63%)
Mkt cap US$54.80M
ROIC (120.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.02
25.88%
(87.69%)
Hold 1|8|12|8|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
17.05%
16.44%
10.15%
(3.50%)
Revenue$M
2.784
2.879
2.821
2.885
(2.29%)
0.75%
(0.39%)
2.55%
Peers (US$54.80M)
Cap (US$)
PE
54.86M
—
Capital
TTM
5Y
10Y
Leveragex
0.968
0.019
0.019
EBIT/Intx
1.449
0.336
0.266
Own earn%
(87.17)
(124.70)
(130.05)
Sh yield%
33.25
19.99
19.86
Owners
Insiders/Inst%
12.59
82.81
Short interest%
2.16
SBC / revenue%
0.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
0–6
$1 testx
0.0
Incr. ROIC%
17